Medicare had banned coverage of weight-loss drugs for 23 years, and what happens next isn't as simple as the headlines ...
March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...
Medicare Advantage insurers leaving certain markets affected more than 1 in 10 Americans enrolled in such plans with prescription drug coverage, a KFF analysis shows.
To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled against the pharmaceutical industry, dismissing both constitutional and ...
A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...
Drug-related provisions of a landmark Biden-era law were tied to a decline in cost-related medication nonadherence among ...
Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.
3dOpinion
Medicare Advantage is facing a reality check — and seniors are the ones who will pay for it
Medicare is the most remarkable advancement in medical-care reimbursement in American history.
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
A lesser‑known Medicare deadline can trigger higher monthly premiums if you miss it. We explain which date to watch and how ...
The Trump administration explored giving the green light to a potential treatment for a broad swath of people on the autism spectrum — but a new drug approval scales back those ...
Don't fall victim to these blunders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results